Jeffrey Lee

Co-Founder & Partner at Northern Light Venture Capital · Joined 2005

View Live Interactive Profile →

Biography

Jeffrey Lee is a co-founder of Northern Light Venture Capital, which has been investing in China focused technology, healthcare and consumer companies since 2005. SEC filings name him, as Jeffrey D. Lee, among the directors of the ultimate general partner entities behind Northern Light's third and fifth fund families, including a 2021 Schedule 13G on Burning Rock Biotech and a 2025 Schedule 13G on Yuanbao Inc. In March 2022 DealStreetAsia reported that he was seeking USD 200 million for a new South Korea focused venture fund.

Career Timeline

2005
Co-founded Northern Light Venture Capital with Feng Deng and Yan Ke.
2021
Named in a Schedule 13G on Burning Rock Biotech Limited as one of the directors of Northern Light Venture Capital III, Ltd.
2022
Reported to be seeking USD 200 million for a new South Korea focused venture fund referred to as the Han River Fund.
2025
Named in a Schedule 13G on Yuanbao Inc. as a director of Northern Light Venture Capital V, Ltd.

Sources & References

SEC Schedule 13G - Yuanbao Inc., filed by Northern Light funds (2025) ↗SEC Schedule 13G - Burning Rock Biotech Limited, filed by Northern Light funds (2021) ↗DealStreetAsia - Northern Light's Jeffrey Lee seeks $200m for new Korean venture fund ↗Northern Light Venture Capital - About ↗Wikipedia - Northern Light Venture Capital ↗